Daniel Bradbury serves as Executive at AMYLIN PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Daniel Bradbury has executed 896 insider transactions totaling $62.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 5, 2024 involved selling 1,425 shares valued at $41.4K.
Daniel Bradbury currently holds 7,125 shares of AMYLIN PHARMACEUTICALS INC (AMLN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel Bradbury has been a net seller of AMLN stock. They have purchased $1.2M and sold $61.2M worth of shares.
Daniel Bradbury's most recent insider trade was on Sep 5, 2024, when they sold 1,425 shares at $29.02 per share.
Get notified when new Form 4 filings are submitted
| $29.02 |
| Planned |
| Sep 5, 2024 | CSTL | $145.6K | Sale | 5,017 | $29.02 | Planned |
| Aug 12, 2024 | CSTL | $38.1K | Sale | 1,431 | $26.65 | Planned |
| Aug 12, 2024 | CSTL | $38.1K | Sale | 1,431 | $26.65 | Planned |
| Aug 12, 2024 | CSTL | $133.8K | Sale | 5,021 | $26.65 | Planned |
| May 25, 2024 | CSTL | $0 | Option Exercise | 8,636 | $N/A | Discretionary |
| May 6, 2024 | CSTL | $182.2K | Sale | 7,393 | $24.64 | Planned |
| May 6, 2024 | CSTL | $196.2K | Sale | 7,963 | $24.64 | Planned |
| May 6, 2024 | CSTL | $196.3K | Sale | 7,967 | $24.64 | Planned |
| Apr 8, 2024 | CSTL | $16.7K | Sale | 819 | $20.45 | Planned |
| Apr 8, 2024 | CSTL | $16.8K | Sale | 820 | $20.45 | Planned |
| Apr 8, 2024 | CSTL | $15.6K | Sale | 761 | $20.45 | Planned |
| Apr 5, 2024 | CSTL | $83.9K | Sale | 4,021 | $20.86 | Planned |
| Apr 5, 2024 | CSTL | $83.8K | Sale | 4,019 | $20.86 | Planned |
| Apr 5, 2024 | CSTL | $77.8K | Sale | 3,731 | $20.86 | Planned |
| Apr 4, 2024 | CSTL | $62.2K | Sale | 2,901 | $21.45 | Planned |
| Apr 4, 2024 | CSTL | $67.1K | Sale | 3,126 | $21.45 | Planned |
| Apr 4, 2024 | CSTL | $67.0K | Sale | 3,125 | $21.45 | Planned |
| Mar 4, 2024 | CSTL | $116.6K | Sale | 5,705 | $20.44 | Planned |
| Mar 4, 2024 | CSTL | $108.2K | Sale | 5,294 | $20.44 | Planned |
| Mar 4, 2024 | CSTL | $48.1K | Sale | 2,262 | $21.28 | Planned |
| Mar 4, 2024 | CSTL | $44.7K | Sale | 2,099 | $21.28 | Planned |
| Mar 4, 2024 | CSTL | $48.1K | Sale | 2,262 | $21.28 | Planned |
| Mar 4, 2024 | CSTL | $116.5K | Sale | 5,701 | $20.44 | Planned |
| Feb 7, 2024 | CSTL | $16.4K | Sale | 708 | $23.20 | Planned |
| Feb 7, 2024 | CSTL | $15.3K | Sale | 658 | $23.20 | Planned |
| Feb 7, 2024 | CSTL | $16.4K | Sale | 708 | $23.20 | Planned |
| Feb 6, 2024 | CSTL | $73.7K | Sale | 3,121 | $23.63 | Planned |
| Feb 6, 2024 | CSTL | $79.4K | Sale | 3,362 | $23.63 | Planned |